Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Oral Hsp90 inhibitor, SNX-5422, attenuates SARS-CoV-2 rep... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Oral Hsp90 inhibitor, SNX-5422, attenuates SARS-CoV-2 replication and dampens inflammation in airway cells.
0
Authors
Ria Goswami
11 more
Ria Goswami
•
Veronica Russell
9 more
•
Sallie Permar
Published
February 23, 2021
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Immunology
Medicine
Microbiology
Internal Medicine
Show all topics
DOI
10.1101/2021.02.23.432479
License
cc-no
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Immunology
Medicine
Microbiology
Internal Medicine
Show all topics
DOI
10.1101/2021.02.23.432479
License
cc-no
